Drug Interaction Report

If you have recently been vaccinated with SARS-CoV-2 rS-protein vaccine, recomb (cvx 313), you should not receive pemivibart for at least 14 days. Treatment with pemivibart may reduce the effectiveness of SARS-CoV-2 rS-protein vaccine, recomb (cvx 313) as it could interfere with the vaccine's ability to produce an adequate immune response to the COVID-19 virus. However, you should continue to receive SARS-CoV-2 rS-protein vaccine, recomb (cvx 313) as indicated by local guidelines based on your condition. Pemivibart should not be used as a replacement for SARS-CoV-2 rS-protein vaccine, recomb (cvx 313). Talk to your doctor or other healthcare providers if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.